Medical Device Registration in Singapore: HSA Guide
Singapore's Health Sciences Authority (HSA) runs one of Asia's most transparent and internationally aligned regulatory systems for medical devices. For many companies, Singapore is the strategic entry point into ASEAN and broader Asia-Pacific markets — and for good reason.
This guide covers everything you need to know about classifying and registering your medical device with HSA.
Why Singapore First?
Before diving into the regulatory details, here's why many medtech companies prioritize Singapore:
- ASEAN reference authority. HSA approval can accelerate registration in Malaysia, Thailand, Philippines, and other ASEAN markets through mutual recognition.
- Reliance pathways. If you have FDA clearance, CE marking, or approval from other recognized authorities, HSA offers expedited review routes.
- Transparent process. Clear timelines, published guidance documents, and responsive regulatory team.
- English-language submissions. No translation requirements.
- Market access. Singapore's healthcare system is a showcase market — devices used here carry credibility across Asia.
HSA Risk Classification
Singapore uses a four-tier risk classification system (Class A–D), broadly aligned with the GHTF/IMDRF framework:
| Class | Risk Level | Examples | Registration Required? |
|---|---|---|---|
| Class A | Low | Tongue depressors, bandages, surgical retractors | No (exempt) |
| Class B | Low-moderate | Powered wheelchairs, pregnancy tests, surgical gloves | Yes |
| Class C | Moderate-high | Ventilators, haemodialysis machines, bone fixation plates | Yes |
| Class D | High | Heart valves, implantable defibrillators, absorbable sutures | Yes |
Key difference from EU/FDA: Class A devices don't require registration with HSA — they only need to comply with general safety requirements and post-market obligations.
Classification Rules
HSA classification follows the ASEAN Medical Device Directive (AMDD) rules, which are closely based on the GHTF classification framework. The rules consider:
- Duration of contact: Transient (< 60 minutes), short-term (< 30 days), long-term (> 30 days)
- Degree of invasiveness: Non-invasive, body orifice, surgically invasive, implantable
- Active vs. non-active: Whether the device relies on an energy source
- Intended purpose: Therapeutic, diagnostic, monitoring
Classification examples by device type:
| Device | Singapore Class | EU Class | FDA Class |
|---|---|---|---|
| Surgical mask | A | I | I (exempt) |
| Blood glucose meter | B | IIa | II |
| Infusion pump | C | IIb | II |
| Coronary stent | D | III | III |
| Mobile health app (wellness) | Not a device | Not a device | Not a device |
| Diagnostic AI software | B–D* | IIa–III* | II–III* |
*Software classification depends on intended purpose and clinical risk of the decision it supports.
Registration Pathways
Once classified, your registration route depends on your device class and whether you have prior approvals from recognized authorities.
Evaluation Routes
HSA offers three evaluation routes for Class B–D devices:
1. Full Evaluation
- For: Devices with no prior approval from a recognized reference authority
- Timeline: 160–310 working days (varies by class)
- Cost: SGD 4,460–12,560 (plus SGD 560 application fee)
- Required: Full technical documentation, clinical evidence, quality management system
2. Abridged Evaluation
- For: Devices already approved by a recognized reference authority (FDA, EU, TGA, Health Canada)
- Timeline: 100–220 working days
- Cost: SGD 2,570–6,810 (plus SGD 560 application fee)
- Required: Reference approval documentation + Singapore-specific dossier
- This is the most common route for international companies
3. Immediate Evaluation
- For: Class B devices already approved by ≥2 recognized reference authorities; Class C with expedited route
- Timeline: Immediate upon submission (Class B); 120 working days (Class C expedited)
- Cost: SGD 1,000–3,340 (plus SGD 560 application fee)
- Required: Proof of reference approvals + basic dossier
The ASEAN CSDT
All submissions use the ASEAN Common Submission Dossier Template (CSDT), which is standardized across ASEAN member states. Preparing one CSDT can serve as the basis for submissions to Singapore, Malaysia, Thailand, Indonesia, Philippines, and other ASEAN markets.
The CSDT has four chapters:
- Administrative information
- Quality management system (ISO 13485)
- Device description and specifications
- Design verification and validation (including clinical evidence)
Authorized Representative Requirement
Foreign manufacturers must appoint a Singapore-based authorized representative (AR) to register devices. The AR:
- Submits the SMDR (Singapore Medical Device Register) application
- Acts as the local liaison with HSA
- Takes on post-market surveillance responsibilities
Choosing the right AR matters — they're your regulatory face in Singapore. Several specialized firms offer AR services, typically bundled with registration support.
Timelines and Costs Summary
| Route | Class B | Class C | Class D |
|---|---|---|---|
| Immediate | Immediate / SGD 1,560 | SGD 3,900 / 120 days* | N/A |
| Abridged | 100 days / SGD 2,570 | 160 days / SGD 4,460 | 220 days / SGD 6,810 |
| Full | 160 days / SGD 4,460 | 220 days / SGD 6,810 | 310 days / SGD 12,560 |
Working days, not calendar days. Fees include SGD 560 application fee + evaluation fee. Class C "Immediate" is an expedited route. Subject to HSA updates — verify at hsa.gov.sg/medical-devices/fees.
Annual retention fees: SGD 39 (Class B), SGD 67 (Class C), SGD 134 (Class D).
Common Mistakes
1. Classifying too conservatively. Some companies default to Class C/D out of caution. Over-classification means higher fees, longer timelines, and more documentation — verify the rules carefully.
2. Not leveraging reliance pathways. If you have FDA clearance or CE marking, always use the abridged route. Full evaluation when you qualify for abridged is wasted time and money.
3. Starting without ISO 13485. HSA requires evidence of a quality management system. If you don't have ISO 13485 certification, factor in 6–12 months for that process first.
4. Ignoring post-market requirements. Singapore has active post-market surveillance. Adverse event reporting is mandatory, and HSA conducts regular audits.
From Singapore to ASEAN
One of Singapore's biggest advantages: it can be your launchpad for ASEAN. HSA approval is recognized as a reference by several ASEAN member states, and the CSDT you prepared for Singapore can be reused (with modifications) for:
- Malaysia (MDA): Recognizes HSA as a reference authority
- Thailand (Thai FDA): ASEAN CSDT accepted
- Philippines (FDA Philippines): ASEAN harmonized framework
- Indonesia (BPOM): Requires additional local testing but accepts CSDT structure
- Vietnam (MOH): Accepts ASEAN CSDT with local requirements
A multi-market ASEAN strategy starting from Singapore can cover 600+ million people across Southeast Asia.
Classify Your Device for Singapore Instantly
Unsure whether your device is Class A, B, C, or D in Singapore? regMD's free classification tool analyzes your device across Singapore and 14 other jurisdictions in seconds.
For the full regulatory strategy — including recommended market entry sequence, timelines, costs, and recognition pathways — get lifetime access for $99.
This article is for informational purposes only and does not constitute regulatory advice. Always consult HSA guidance documents or a qualified regulatory consultant for your specific device.